Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up
Doravirine works as well as efavirenz with fewer CNS side-effects
Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants
Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection
Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy
Truvada PrEP use rising in United States, especially among men
One third of TB cases in Eastern European HIV clinic survey multi-drug resistant
Australia performs best in HIV treatment cascade – 62% with undetectable viral load
Generic antiretrovirals could save NHS £1.25 billion over 5 years, study finds
